当前位置: X-MOL 学术Nat. Biotechnol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The biopharmaceutical anomaly.
Nature Biotechnology ( IF 33.1 ) Pub Date : 2020-06-30 , DOI: 10.1038/s41587-020-0593-1
Melanie Senior 1
Affiliation  

Investment and funding has continued to flow into biotech, unlike most business sectors. But with healthcare and hospital budgets increasingly under pressure, do belt-tightening and consolidation lie ahead? Melanie Senior investigates, with additional reporting by Riku Lähteenmäki.

中文翻译:

生物制药异常。

与大多数业务部门不同,投资和资金继续流入生物技术。但是,随着医疗保健和医院预算的压力越来越大,紧缩和整合是否摆在眼前?Melanie Senior进行了调查,RikuLähteenmäki还提供了其他报告。
更新日期:2020-06-30
down
wechat
bug